Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity.
Baniasadi S, Eftekhari P, Tabarsi P, Fahimi F, Raoufy MR, Masjedi MR, Velayati AA.
Baniasadi S, et al.
Eur J Gastroenterol Hepatol. 2010 Oct;22(10):1235-8. doi: 10.1097/MEG.0b013e32833aa11b.
Eur J Gastroenterol Hepatol. 2010.
PMID: 20461008
Clinical Trial.
Patients were randomized into two groups. In group I (n=32), drug regimen included daily doses of isoniazid, rifampicin, pyrazinamide, and ethambutol. Patients in group II (n=28) were treated with the same regimen and NAC. The patients were followed up for 2 weeks. …
Patients were randomized into two groups. In group I (n=32), drug regimen included daily doses of isoniazid, rifampicin, pyrazinamide …